Le Lézard
Classified in: Covid-19 virus
Subjects: Conference Call, Webcast

Coty Outlines Long-Term Growth Plan and Reclaims Position as a True Beauty Powerhouse


Coty Inc. (NYSE: COTY) ("Coty" or "the Company"), one of the world's leading beauty companies and global leader in fragrance, today will host an Investor Day at the New York Stock Exchange. At the event, Coty will provide an update on the significant progress made on the Company's six strategic pillars, elaborate on key upcoming operational milestones, report on its comprehensive transformation "All-In To Win" program, and announce its financial goals through FY25 and beyond.

Sue Y. Nabi, Chief Executive Officer of Coty, said: "Coty has reclaimed its position as a true beauty powerhouse. We expect to outperform the beauty market through FY25 and beyond. I am very proud of the significant progress our teams have made, delivering against each of our strategic pillars. I am more confident than ever in Coty's future and our ability to deliver significant value for all of our stakeholders.

Coty's unique and beautiful portfolio of brands, our talented team, and our single-minded focus on delivering sustainable, profitable growth, coupled with targeted reinvestment, are enabling us to evolve. We continue to capitalize on the tremendous growth opportunities in prestige fragrances, skincare, China, clean beauty and e-commerce."

Event Overview

During today's event, members of Coty's leadership team will outline how the business has continued to deliver enhanced performance against its previously communicated strategic priorities, including:

In addition, presenters will also provide insights into the Company's growth framework and the numerous initiatives underway that are transforming and positioning Coty to succeed, including:

Financial Outlook

The Company is continuing to expand gross margin and cost savings, allowing it to reinvest into key strategic initiatives and simultaneously deliver annual profit growth, targeting an adjusted EBITDA of at a minimum $900 million for FY22, and approaching $1 billion in CY22. The growing confidence in business progress and capital structure improvement leads Coty to raise its FY22 adjusted EPS guidance to $0.20-0.24 from its previous guidance of $0.19-0.23.

Over the coming years, Coty expects to benefit from an improving beauty market, including a stronger U.S. and Chinese market, a robust rebound in Travel Retail, and steady improvement across Europe. Based on this favorable market backdrop, the strong performance of recent brand repositioning and product launches, and Coty's robust category and market expansion plans, the Company is announcing the following financial targets through FY25 and beyond:

Webcast Information

Coty's Investor Day presentation will be available via webcast at investors.coty.com from 8:30 a.m. ET (Eastern Time), concluding at approximately 12:00 p.m. ET. The webcast and presentation materials can be accessed through Coty's investor relations website. A replay of the webcast will be available following the event.

About Coty Inc.

Coty is one of the world's largest beauty companies with an iconic portfolio of brands across fragrance, color cosmetics, and skin and body care. Coty is the global leader in fragrance, and number three in color cosmetics. Coty markets, sells and distributes the products in approximately 130 countries and territories. Coty and its brands are committed to a range of social causes as well as seeking to minimize its impact on the environment. For additional information about Coty Inc., please visit www.coty.com.

Forward Looking Statements

Certain statements in this press release are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements reflect the Company's current views with respect to, among other things, the impact of COVID-19 and potential recovery scenarios, the Company's comprehensive transformation agenda (the "Transformation Plan"), strategic planning, targets, segment reporting and outlook for future reporting periods (including the extent and timing of revenue, expense and profit trends and changes in operating cash flows and cash flows from operating activities and investing activities), the impact of the Wella divestiture and the related transition services (the "Wella TSA"), the Company's future operations and strategy (including the expected implementation and related impact of its strategic priorities), ongoing and future cost efficiency, optimization and restructuring initiatives and programs, strategic transactions (including their expected timing and impact), the Company's capital allocation strategy and payment of dividends (including suspension of dividend payments and the duration thereof), investments, licenses and portfolio changes, synergies, savings, performance, cost, timing and integration of acquisitions, including the strategic partnership with Kylie Jenner and the strategic partnership with Kim Kardashian West, future cash flows, liquidity and borrowing capacity, timing and size of cash outflows and debt deleveraging, the availability of local government funding or reimbursement programs in connection with COVID-19 (including expected timing and amounts), the timing and extent of any future impairments, and synergies, savings, impact, cost, timing and implementation of the Company's Transformation Plan, including operational and organizational structure changes, operational execution and simplification initiatives, fixed cost reductions, supply chain changes, e-commerce and digital initiatives, and the priorities of senior management. These forward-looking statements are generally identified by words or phrases, such as "anticipate", "are going to", "estimate", "plan", "project", "expect", "believe", "intend", "foresee", "forecast", "will", "may", "should", "outlook", "continue", "temporary", "target", "aim", "potential", "goal" and similar words or phrases. These statements are based on certain assumptions and estimates that we consider reasonable, but are subject to a number of risks and uncertainties, many of which are beyond our control, which could cause actual events or results (including our financial condition, results of operations, cash flows and prospects) to differ materially from such statements, including risks and uncertainties relating to:

When used herein, the term "includes" and "including" means, unless the context otherwise indicates, "including without limitation". More information about potential risks and uncertainties that could affect the Company's business and financial results is included under the heading "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" in the Company's Quarterly Report on Form 10-Q for the period ended September 30, 2021 and annual report on Form 10-K for the year ended June 30, 2021 and other periodic reports the Company has filed and may file with the SEC from time to time.

All forward-looking statements made in this release are qualified by these cautionary statements. These forward-looking statements are made only as of the date of this release, and the Company does not undertake any obligation, other than as may be required by applicable law, to update or revise any forward-looking or cautionary statements to reflect changes in assumptions, the occurrence of events, unanticipated or otherwise, or changes in future operating results over time or otherwise.


These press releases may also interest you

at 08:30
According to a new report published by Dialogue Health Technologies Inc., Canada's leading health and wellness virtual care platform, Canadians' overall well-being is at a low point as they struggle with lifestyle challenges around sleep and physical...

at 08:30
Applied Biological Laboratories Inc, the biotechnology company behind the innovative new cold and flu remedy Biovanta and other scientifically validated natural products, has named Rob Keen its new CEO, effective April 24. "I am...

at 08:30
Zoomd Technologies Ltd.  and its wholly-owned subsidiary Zoomd Ltd. (collectively, "Zoomd" or the "Company"), the marketing technology (MarTech) user-acquisition and engagement platform, today reported its financial results for the three months and...

at 08:00
Catheter Precision, Inc. ($VTAK), a leading MedTech company specializing in innovative products for cardiac electrophysiology, including its VIVO™ and LockeT products, announces that is has received its first purchase order (PO) for LockeT...

at 07:35
Arrowhead Pharmaceuticals, Inc. announced today that it has dosed the first subjects in a Phase 1/2a clinical trial (NCT06209177) of ARO-CFB, the company's investigational RNA interference (RNAi) therapeutic, in up to 66 healthy volunteers and...

at 07:35
Fortive Corporation ("Fortive") today announced financial results for the first quarter of 2024. For the first quarter, net earnings were $207 million. For the same period, adjusted net earnings were $295 million, which excludes the $63 million...



News published on and distributed by: